{"id":848,"date":"2024-07-31T17:04:31","date_gmt":"2024-07-31T08:04:31","guid":{"rendered":"https:\/\/www.ssri.com\/china\/e\/medicalnews\/?p=848"},"modified":"2024-08-14T17:12:08","modified_gmt":"2024-08-14T08:12:08","slug":"new-drug-approvals-by-the-nmpa-july-2024","status":"publish","type":"post","link":"https:\/\/www.ssri.com\/china\/e\/medicalnews\/848\/","title":{"rendered":"New Drug Approvals by the NMPA - July 2024"},"content":{"rendered":"<p>\n<strong><u><strong>Imported drugs:<\/strong><\/u><\/strong><br \/>\n\u25a1\u3000BIMZELX (bimekizumab) \u2013 marketed by UCB Pharma S.A.<br \/>\n\u25a1\u3000MOUNJARO (tirzepatide) \u2013 new indication - marketed by Eli Lilly and Company<br \/>\n\u25a1\u3000SMYRAF (peficitinib) \u2013 marketed by Astellas Pharma Inc.<br \/>\n\u25a1\u3000VONVENDI (vonicog alfa) \u2013 marketed by Takeda Pharmaceuticals U.S.A., Inc.<br \/>\n\u25a1\u3000VYVGART HYTRULO (efgartigimod alfa) \u2013 marketed by argenx BV<br \/>\n\u25a1\u3000Methotrexate injection \u2013 marketed by Medac Gesellschaft f\u00fcr klinische Spezialpr\u00e4parate mbH<br \/>\n\u25a1\u3000Ursodeoxycholic acid oral suspension \u2013 marketed by Dr. Falk Pharma GmbH<\/p>\n<p><strong><u><strong>Domestic drugs:<\/strong><\/u><\/strong><br \/>\n\u25a1\u3000Bilessglu (chiglitazar) \u2013 new indication - marketed by Chengdu Chipscreen Pharmaceutical Ltd.<br \/>\n\u25a1\u3000\u60e0\u4f18\u52a0 - Hui You Jia (Insulin degludec and insulin aspart Injection) \u2013 marketed by Huisheng Bio-pharmacutical Co., Ltd.<br \/>\n\u25a1\u3000\u6cf0\u7231 - Tai Ai (telitacicept) \u2013 new indication - marketed by RemeGen Co., Ltd.<br \/>\n\u25a1\u3000\u6cfd\u5143\u5b89 - Ze Yuan An (ganaxolone) \u2013 marketed by Marinus Pharmaceuticals, Inc.<br \/>\n\u25a1\u3000Alfacalcidol drops \u2013 marketed by Hubei Jinluo Silk Cloth Co., Ltd.<br \/>\n\u25a1\u3000Emtricitabine and tenofovir disoproxil fumarate tablets \u2013 marketed by Qilu Pharmaceutical Co., Ltd.<br \/>\n\u25a1\u3000Entacapone tablets (II) \u2013 marketed by SJZ No.4 Pharmaceutical Co., Ltd.<br \/>\n\u25a1\u3000Frovatriptan tablet \u2013 marketed by C.P Pharmaceutical (Qingdao) Co. Ltd.<br \/>\n\u25a1\u3000Irbesartan and amlodipine besilate tablets (I) and (III) \u2013 marketed by Jiangxi Shimei Pharmaceutical Co., Ltd.<br \/>\n\u25a1\u3000Meropenem and sodium chloride injection \u2013 marketed by Hunan Kelun Pharmaceutical Co., Ltd.<br \/>\n\u25a1\u3000Multi-trace elements injection (III) \u2013 marketed by Yangpu Jingtai Pharmaceutical Co., Ltd.<br \/>\n\u25a1\u3000Vancomycin hydrochloride capsules \u2013 marketed by Speed Safety Healthy (Hangzhou) Pharmaceutical Co., Ltd.<br \/>\n&nbsp;<br \/>\n(Source: BaiPharm)<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Imported drugs: \u25a1\u3000BIMZELX (bimekizumab) \u2013 marketed by UCB Pharma S.A. \u25a1\u3000MOUNJARO (tirzepatide) \u2013 new indication - marketed by Eli Lilly and Company \u25a1\u3000SMYRAF (peficitinib) \u2013 marketed by Astellas Pharma Inc. \u25a1\u3000VONVENDI (vonicog alfa) \u2013 marketed by Takeda Pharmaceuticals U.S.A., Inc. \u25a1\u3000VYVGART HYTRULO (efgartigimod alfa) \u2013 marketed by argenx BV \u25a1\u3000Methotrexate injection \u2013 marketed by Medac Gesellschaft f\u00fcr klinische Spezialpr\u00e4parate mbH \u25a1\u3000Ursodeoxycholic acid oral suspension \u2013 marketed by Dr. Falk Pharma GmbH Domestic drugs: \u25a1\u3000Bilessglu (chiglitazar) \u2013 new indication - marketed by Chengdu Chipscreen Pharmaceutical Ltd. \u25a1\u3000\u60e0\u4f18\u52a0 - Hui You Jia (Insulin degludec and insulin aspart Injection) \u2013 marketed by Huisheng Bio-pharmacutical Co., Ltd. \u25a1\u3000\u6cf0\u7231 - Tai Ai (telitacicept) \u2013 new...  <a class=\"excerpt-read-more\" href=\"https:\/\/www.ssri.com\/china\/e\/medicalnews\/848\/\" title=\"Read New Drug Approvals by the NMPA - July 2024\">Read more &raquo;<\/a><\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-848","post","type-post","status-publish","format-standard","hentry","category-medicalnews"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.ssri.com\/china\/e\/medicalnews\/wp-json\/wp\/v2\/posts\/848","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ssri.com\/china\/e\/medicalnews\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ssri.com\/china\/e\/medicalnews\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ssri.com\/china\/e\/medicalnews\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ssri.com\/china\/e\/medicalnews\/wp-json\/wp\/v2\/comments?post=848"}],"version-history":[{"count":3,"href":"https:\/\/www.ssri.com\/china\/e\/medicalnews\/wp-json\/wp\/v2\/posts\/848\/revisions"}],"predecessor-version":[{"id":851,"href":"https:\/\/www.ssri.com\/china\/e\/medicalnews\/wp-json\/wp\/v2\/posts\/848\/revisions\/851"}],"wp:attachment":[{"href":"https:\/\/www.ssri.com\/china\/e\/medicalnews\/wp-json\/wp\/v2\/media?parent=848"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ssri.com\/china\/e\/medicalnews\/wp-json\/wp\/v2\/categories?post=848"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ssri.com\/china\/e\/medicalnews\/wp-json\/wp\/v2\/tags?post=848"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}